Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Insights Into The Emerging Health Monitoring Medical Device Market


Deepak Prakash

Deepak Prakash, Global Director of Marketing, Digital Health, for Vancive Medical Technologies.

Share this!

September 24, 2015 | by Sarah Massey

Though patient health monitoring systems have been used in hospitals and care centers for years, the medical device industry is currently experiencing a technology upgrade. Earlier this month, the Xtalks Blog published a blog post on the current trend of crossover medical devices; those tools used both by healthcare professionals, and the average health-conscious consumer.

To get an insider’s perspective on where the health monitoring medical device industry is heading, and how these devices could improve outcomes for clinical trials, I spoke with Deepak Prakash, Global Director of Marketing, Digital Health, for Vancive Medical Technologies. Vancive just recently launched their first patient monitoring device using their novel Metria™ Informed Health Platform.

How does Vancive’s Metria IH1™ Informed Health Monitoring System compare to other systems on the market?

Metria™ is one of our offerings in this emerging trend of connected health products. Our vision is to start with activity and lifestyle monitoring, and then go into some of the deeper physiological monitoring as we expand the portfolio. But the connected health market is generally at its early stages. Any connected health product differs substantially from existing legacy monitoring products that you would find in hospitals.

The new family of connected health products – using mobility solutions and delivering healthcare wirelessly – is very different [from traditional patient monitoring devices]. Within that family of activity tracking products, the Metria IH1™ is different in terms of its form factor.

Metria IH1™ is very simple – something you stick on the skin. Secondly, we’re disposable whereas a lot of them are durable. Thirdly, because of the nature of the device, (how it’s used and the accuracy), we focus mainly on the healthcare service providers, as oppose to direct-to-consumer.

Because the space is so early and everybody is discovering the beauty of new sensors, wireless mobility solutions, and apps, it differs greatly from legacy systems that are out there. The vision for this space – and certainly some of our products as we decide to grow – is to start to replace some of the legacy monitoring systems because they’re old, very complex, expensive, and they can affect the quality of life of the user.

In every industry – whether it’s travel, banking or news – everything is being delivered at your fingertips now through smartphones and other technologies. Why not healthcare too?

Do you think Metria IH1™ has an application in patient monitoring during clinical trials?

Yes, very much so. That’s a big area of focus for us with our [Metria IH1™]. One of the things with clinical trials, is that they are evolving in terms of getting more accurate data about the lifestyle of the patient when they are taking a drug, or being studied. A lot of times it’s all very subject to recall by the patient. For example, “Do you remember what you felt like on Tuesday,” or, “Do you remember being able to walk without pain?”

These kinds of new technologies are definitely going to change the clinical trial landscape. Because it’s of great interest, I’m attending a seminar conference in New York at the end of this month where specifically wearable and visual technologies as being talked about, [and how they can] make a difference in clinical trials.

Today, the Metria IH1™ is being used in medical professional services, clinical trials and health and wellness. The next generation we’re working on will have traditional physiological monitoring abilities, such as a heart rate monitor.

Read Page 2



Colorants in Devices: Successfully Integrated Strategies towards Regulatory Approval

The Use of High Resolution Accurate Mass Spectrometry

Keywords: Medical Device, Health Monitoring, Clinical Trials



Share this with your colleagues!

Precision Medicine and the Paradigm Shift In The Development of Novel Cancer Therapies

September 17, 2015 - To further understand how the paradigm shift in cancer research, diagnosis and treatment will affect how drugs are developed and clinical trials are conducted in Canada, I spoke to Dr. Sian Bevan, director of research for the Canadian Cancer Society.

Medical Device Innovation: Blurring the Lines Between Medical Necessity and Personal Accessory

September 9, 2015 - As sales of wearable medical monitors rise, and healthy, average consumers increasingly look for high-tech gadgets to monitor their health, device manufacturers are developing technology which can be marketed to both healthy individuals as well as those with specific medical conditions.

Recent Medical Applications of 3-D Printing and the Future of Medical Device Manufacture

September 2, 2015 - While the use of 3-D printers in the pharmaceutical industry is still in its infancy, three-dimensional printing technology has been used for other applications such as medical device manufacture and improvements in research tools available for drug testing.

Printing Your Prescription: How 3-D Printing Technology is Affecting the Pharmaceutical Industry

August 26, 2015 - In the wake of the FDA’s first approved 3-D printed drug – which happened earlier this year – and the promise of three others in the works, experts are predicting that the future of the pharmaceutical industry lies in the development of printable drug products.

Are There Adequate Alternatives to Animal Testing?

August 19, 2015 - Three promising in vitro and in silico technologies including, Modular Immune in vitro Construct (MIMIC), Organ-on-a-Chip and Computer Models of Adverse Drug Reactions, which could reduce the need for animals in research, are reviewed in more detail.


Copyright © 2016-2017 Honeycomb Worldwide Inc.